Therapeutic drug monitoring of antimicrobialsROBERTS, Jason A; NORRIS, Ross; PATERSON, David L et al.British journal of clinical pharmacology. 2012, Vol 73, Num 1, pp 27-36, issn 0306-5251, 10 p.Article

Target Concentration Intervention in Oncology: Where Are We At?SALEEM, Mohamed; DIMESKI, Goce; KIRKPATRICK, Carl M et al.Therapeutic drug monitoring. 2012, Vol 34, Num 3, pp 257-265, issn 0163-4356, 9 p.Article

Safe and Effective Variability—A Criterion for Dose IndividualizationHOLFORD, Nicholas H. G; BUCLIN, Thierry.Therapeutic drug monitoring. 2012, Vol 34, Num 5, pp 565-568, issn 0163-4356, 4 p.Article

Limited predictability of amikacin clearance in extreme premature neonates at birthALLEGAERT, Karel; ANDERSON, Brian J; COSSEY, Veerle et al.British journal of clinical pharmacology. 2006, Vol 61, Num 1, pp 39-48, issn 0306-5251, 10 p.Article

Quantitative justification for target concentration intervention: parameter variability and predictive performance using population pharmacokinetic models for aminoglycosidesMATTHEWS, Ivan; KIRKPATRICK, Carl; HOLFORD, Nicholas et al.British journal of clinical pharmacology. 2004, Vol 58, Num 1, pp 8-19, issn 0306-5251, 12 p.Article

Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patientsDENG, C; LIU, T; WU, K et al.Journal of clinical pharmacy and therapeutics (Print). 2013, Vol 38, Num 6, pp 480-489, issn 0269-4727, 10 p.Article

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis : a population pharmacokinetic studyHENNIG, Stefanie; NORRIS, Ross; KIRKPATRICK, Carl M. J et al.British journal of clinical pharmacology. 2008, Vol 65, Num 4, pp 502-510, issn 0306-5251, 9 p.Article

Importance of hematocrit for a tacrolimus target concentration strategySTØRSET, Elisabet; HOLFORD, Nick; MIDTVEDT, Karsten et al.European journal of clinical pharmacology. 2014, Vol 70, Num 1, pp 65-77, issn 0031-6970, 13 p.Article